Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

PORTOLA PHARMACEUTICALS INC (PTLA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $17.98 Metrics
OS: 78.5 M -390 % ROE
Market cap: $1.41 B -100 % ROIC
Net cash: $221 M $2.81 per share
EV: $1.19 B

 
TTM Valuation
EBITDA ($253) M
EBIT ($256) M
EPS ($3.88)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
Revenues116.640.122.535.512.19.610.572.0
            Revenue growth190.7%78.0%-36.5%194.2%25.4%-8.6%-85.4%-7.7%
Cost of goods sold44.418.10.40.00.00.00.00.0
Gross profit72.322.022.135.512.19.610.572.0
            Gross margin62.0%54.9%98.2%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative218.9151.291.158.238.923.615.4 
Research and development124.6216.2203.7246.9200.4123.679.349.7
General and administrative       11.5
EBIT-268.4-345.3-272.7-269.6-227.2-137.6-84.210.8
            EBIT margin-230.1%-860.5%-1209.4%-759.3%-1882.1%-1429.3%-799.3%15.0%
Pre-tax income-292.9-350.5-285.6-268.1-226.9-137.1-83.411.4
Income taxes0.00.00.00.0-0.40.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.2%0.0%0.0%0.0%
Net income-290.7-350.2-286.1-269.0-226.5-137.1-83.411.4
            Net margin-249.2%-872.7%-1268.9%-757.8%-1876.6%-1424.7%-791.5%15.8%
 
Diluted EPS($4.06)($5.31)($4.81)($4.76)($4.36)($3.19)($3.65)$5.55
Shares outstanding (diluted)71.666.059.556.552.043.022.82.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy